Trying to eliminate lymphatic filariasis, or “big foot,” from a country is like trying to permanently rid your garden of invasive plants and weeds.
May 24, 2017
In April 2017, the END in Africa project team was awarded the 2016 Impact Award for Program Excellence. This award recognizes the outstanding contributions of an individual staff member or team to FHI 360’s leadership in global and domestic health, education and development. This contribution may have been demonstrated by promoting integrated development solutions and/or
May 2, 2017
Persistent ‘hotspots’ of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana
Among the 216 districts in Ghana, 98 were declared endemic for lymphatic filariasis in 1999 after mapping. Pursuing the goal of elimination, WHO recommends annual treatment using mass drugs administration (MDA) for at least 5 years. MDA was started in the country in 2001 and reached national coverage in 2006. By 2014, 69 districts had
- @ENDinAfrica award for program excellence highlights progress on #NTDs https://t.co/tkfyyOsTp4 @fhi360 #BeatNTDs
- RT @RTIfightsNTDs: Congrats Togo, 1st in sub-Saharan Africa to eliminate lymphatic filariasis! Proud of MOH & partners @USAIDGH @ENDinAfric…
- Honored to work with partners like @USAIDGH @RTIfightsNTDs to fight NTDs in sub-Saharan Africa. We can #beatNTDs
Through the work of its END in Africa and END in Asia programs, FHI 360 is advancing USAID's goal of contributing to the global elimination of NTD by reducing prevalence of seven diseases—lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis (snail fever), trachoma (blinding eye infection) and three soil-transmitted helminths (hookworm, roundworm, and whipworm).